A Maryland based biotechnology company announced the coronavirus vaccine it developed is moving into an efficacy trial phase.
Katie Johnston reports.
A Maryland based biotechnology company announced the coronavirus vaccine it developed is moving into an efficacy trial phase.
Katie Johnston reports.